SPIROCYCLIC CYCLOHEXANE COMPOUNDS WITH ANALGESIC ACTIVITY
申请人:Merla Beatrix
公开号:US20090111842A1
公开(公告)日:2009-04-30
Spirocyclic cyclohexane compounds corresponding to formula I
a process for manufacturing such compounds, pharmaceutical compositions that contain such compounds, and the use of such spirocyclic cyclohexane compounds for the production of pharmaceuticals, and particularly for the treatment of pain.
Substituted amide compounds corresponding to formula I:
processes for preparing them, pharmaceutical compositions containing these compounds, and the use of substituted amide derivatives for the preparation of medicaments for the treatment of pain and various other conditions.
Substituted sulfonamide compounds corresponding to formula I
pharmaceutical compositions comprising them, a process for preparing them, and the use of such compounds to treat or inhibit pain and other disorders or disease states.
SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS OPIOID RECEPTOR LIGANDS
申请人:MERLA Beatrix
公开号:US20090005427A1
公开(公告)日:2009-01-01
Substituted oxadiazole compounds corresponding to formula I:
in which X denotes CH, CH
2
, CH═CH, CH
2
CH
2
, CH
2
CH═CH or CH
2
CH
2
CH
2
; R
1
denotes aryl or heteroaryl, in each case unsubstituted or mono- or polysubstituted; or a C
1-3
alkyl group-linked aryl or heteroaryl group, in each case unsubstituted or mono- or polysubstituted; R
2
denotes aryl or heteroaryl, in each case unsubstituted or mono- or polysubstituted; a C
1-3
alkyl chain-attached aryl group, in each case unsubstituted or mono- or polysubstituted; and R
3
and R
4
independently denote H; C
1-6
alkyl, in each case saturated or unsaturated, branched or unbranched, wherein R
3
and R
4
do not simultaneously mean H; or R
3
and R
4
together denote CH
2
CH
2
OCH
2
CH
2
, or (CH
2
)
3-6
. The compounds have an affinity for the μ-opioid receptor and may take the form of the racemate; enantiomers, diastereomers, mixtures of enantiomers or diastereomers, an individual enantiomer or diastereomer, a free base, or a salt with a physiologically acceptable acid.
Substituted imidazoline derivatives corresponding to Formula I:
a method for producing them from substituted aldehyde compounds of Formula B:
and the use of such imidazoline derivatives and aldehyde compounds to treat pain, depression, urinary incontinence, diarrhea, pruritus, alcohol and drug misuse, drug dependency, lethargy and/or anxiety.